UBS raised the firm’s price target on Visteon (VC) to $165 from $164 and keeps a Buy rating on the shares. Visteon reported a headline beat and raise, with guidance reintroduced above consensus estimates, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VC: